670 related articles for article (PubMed ID: 2508585)
1. Optimal daily levothyroxine dose in primary hypothyroidism. Its relation to pretreatment thyroid hormone indexes.
Kabadi UM
Arch Intern Med; 1989 Oct; 149(10):2209-12. PubMed ID: 2508585
[TBL] [Abstract][Full Text] [Related]
2. Serum thyrotropin in primary hypothyroidism. A possible predictor of optimal daily levothyroxine dose in primary hypothyroidism.
Kabadi UM; Jackson T
Arch Intern Med; 1995 May; 155(10):1046-8. PubMed ID: 7748047
[TBL] [Abstract][Full Text] [Related]
3. Estimation of a physiologic replacement dose of levothyroxine in elderly patients with hypothyroidism.
Davis FB; LaMantia RS; Spaulding SW; Wehmann RE; Davis PJ
Arch Intern Med; 1984 Sep; 144(9):1752-4. PubMed ID: 6433829
[TBL] [Abstract][Full Text] [Related]
4. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism.
Kabadi UM
J Fam Pract; 1987 May; 24(5):473-7. PubMed ID: 3106558
[TBL] [Abstract][Full Text] [Related]
5. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
[TBL] [Abstract][Full Text] [Related]
6. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
[TBL] [Abstract][Full Text] [Related]
7. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment.
Parle JV; Franklyn JA; Cross KW; Jones SR; Sheppard MC
Br J Gen Pract; 1993 Mar; 43(368):107-9. PubMed ID: 8323787
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy.
Wadwekar D; Kabadi UM
Exp Clin Endocrinol Diabetes; 2004 Jul; 112(7):373-7. PubMed ID: 15239022
[TBL] [Abstract][Full Text] [Related]
9. Noncompliance with medical treatment: pseudomalabsorption of levothyroxine.
Eledrisi MS; Szymajda A; Alshanti M; Urban RJ
South Med J; 2001 Aug; 94(8):833-6. PubMed ID: 11549198
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroxinemia in patients receiving thyroid replacement therapy.
Grund FM; Niewoehner CB
Arch Intern Med; 1989 Apr; 149(4):921-4. PubMed ID: 2705841
[TBL] [Abstract][Full Text] [Related]
11. Laboratory tests for evaluating thyroid therapy.
Kabadi UM
Am Fam Physician; 1982 Sep; 26(3):183-8. PubMed ID: 6180620
[TBL] [Abstract][Full Text] [Related]
12. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
[TBL] [Abstract][Full Text] [Related]
13. Levothyroxine dosage is associated with stability of thyroid-stimulating hormone values.
Pecina J; Garrison GM; Bernard ME
Am J Med; 2014 Mar; 127(3):240-5. PubMed ID: 24333203
[TBL] [Abstract][Full Text] [Related]
14. [The effect of three kinds of thyroid hormone preparations on serum thyroid hormone and TSH in primary hypothyroidism].
Dai W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Dec; 12(6):421-4. PubMed ID: 2151260
[TBL] [Abstract][Full Text] [Related]
15. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial.
Bolk N; Visser TJ; Nijman J; Jongste IJ; Tijssen JG; Berghout A
Arch Intern Med; 2010 Dec; 170(22):1996-2003. PubMed ID: 21149757
[TBL] [Abstract][Full Text] [Related]
16. Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine.
Banovac K; Papic M; Bilsker MS; Zakarija M; McKenzie JM
Arch Intern Med; 1989 Apr; 149(4):809-12. PubMed ID: 2495780
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial.
Valizadeh M; Seyyed-Majidi MR; Hajibeigloo H; Momtazi S; Musavinasab N; Hayatbakhsh MR
Endocr Res; 2009; 34(3):80-9. PubMed ID: 19701833
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
19. Do abnormal thyroid stimulating hormone level values result in treatment changes? A study of patients on thyroxine in one general practice.
De Whalley P
Br J Gen Pract; 1995 Feb; 45(391):93-5. PubMed ID: 7702890
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the optimal thyroxine dose with the TRH test for replacement and suppression therapy].
Erne P; Staub JJ; Althaus B; Fleig Y; Girard J
Schweiz Med Wochenschr; 1983 Dec; 113(50):1922-3. PubMed ID: 6420884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
